Ionis Pharmaceuticals, Inc. (IONS)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS4622221004
27.31 USD
-3.60% today Updated 13 Nov 2026 10:46
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Ionis Pharmaceuticals, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:46. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
24 Feb 2027
in 103 days · 08:00 · estimate -1.19
Last results
-0.40 vs -0.93 estimated
09 Nov 2026 · Beat +56.8%
Beat the estimate
12 of 12
0 missed · 0 in line · 12 beats in a row
Average surprise
+75.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 08:00 | -1.19 | — | — | Upcoming |
| 09 Nov 2026 07:00 | -0.93 | -0.40 | +56.8% | Beat |
| 29 Jul 2026 07:00 | -0.88 | -0.42 | +51.7% | Beat |
| 29 Apr 2026 07:00 | -0.77 | -0.30 | +60.9% | Beat |
| 25 Feb 2026 07:00 | -1.22 | -1.15 | +5.6% | Beat |
| 29 Oct 2025 07:00 | -1.05 | -0.61 | +41.8% | Beat |
| 30 Jul 2025 07:00 | 0.16 | 0.85 | +415.1% | Beat |
| 30 Apr 2025 07:00 | -1.03 | -0.92 | +10.4% | Beat |
| 19 Feb 2025 07:00 | -0.84 | -0.43 | +49.0% | Beat |
| 06 Nov 2024 07:00 | -0.98 | -0.72 | +26.1% | Beat |
| 01 Aug 2024 07:00 | -0.76 | -0.24 | +68.6% | Beat |
| 07 May 2024 07:00 | -0.83 | -0.77 | +7.3% | Beat |
| 21 Feb 2024 07:00 | -0.75 | 0.12 | +115.8% | Beat |
| 02 Nov 2023 07:00 | -0.89 | -0.85 | +4.8% | Beat |
| 09 Aug 2023 11:00 | -0.70 | -0.41 | +42.5% | Beat |
| 03 May 2023 07:00 | -0.76 | -0.68 | +10.4% | Beat |
| 22 Feb 2023 07:00 | -0.86 | -1.18 | -37.5% | Miss |
| 09 Nov 2022 07:00 | -0.53 | -0.16 | +69.7% | Beat |
| 09 Aug 2022 07:00 | -0.47 | -0.56 | -20.1% | Miss |
| 04 May 2022 07:00 | -0.52 | -0.27 | +47.1% | Beat |
| 24 Feb 2022 07:00 | 0.31 | 1.55 | +393.5% | Beat |
| 03 Nov 2021 07:00 | -0.32 | -0.34 | -5.3% | Miss |
| 04 Aug 2021 07:00 | -0.32 | -0.26 | +19.0% | Beat |
| 05 May 2021 07:00 | -0.25 | -0.32 | -25.6% | Miss |
| 24 Feb 2021 07:00 | 0.30 | 0.44 | +48.8% | Beat |
| 04 Nov 2020 07:00 | -0.16 | -0.22 | -37.5% | Miss |
| 05 Aug 2020 07:00 | -0.28 | -0.23 | +17.9% | Beat |
| 06 May 2020 07:00 | -0.11 | -0.35 | -204.4% | Miss |
| 26 Feb 2020 07:00 | 1.03 | 1.33 | +29.2% | Beat |
| 06 Nov 2019 07:00 | -0.32 | 0.18 | +155.9% | Beat |
| 07 Aug 2019 07:00 | -0.20 | -0.01 | +95.0% | Beat |
| 09 May 2019 07:00 | 0.78 | 0.62 | -20.5% | Miss |
| 27 Feb 2019 07:00 | — | 0.20 | +19,707.8% | Beat |
| 06 Nov 2018 07:00 | -0.17 | -0.03 | +82.5% | Beat |
| 07 Aug 2018 07:00 | -0.19 | -0.29 | -56.4% | Miss |
| 04 May 2018 07:00 | -0.15 | -0.01 | +93.5% | Beat |
| 27 Feb 2018 07:00 | -0.04 | 0.02 | +150.0% | Beat |
| 07 Nov 2017 07:00 | -0.08 | — | +100.0% | — |
| 08 Aug 2017 07:00 | -0.06 | -0.09 | -57.8% | Miss |
| 09 May 2017 07:00 | -0.31 | 0.03 | +109.6% | Beat |
| 28 Feb 2017 07:00 | -0.11 | 0.24 | +310.1% | Beat |
| 09 Nov 2016 07:00 | 0.04 | 0.06 | +38.9% | Beat |
| 09 Aug 2016 07:00 | -0.52 | -0.47 | +9.6% | Beat |
| 04 May 2016 07:00 | -0.54 | -0.52 | +3.7% | Beat |
| 25 Feb 2016 08:00 | -0.54 | -0.59 | -8.4% | Miss |
| 09 Nov 2015 07:00 | -0.33 | -0.30 | +8.3% | Beat |
| 04 Aug 2015 09:00 | 0.29 | 0.29 | +1.2% | Beat |
| 05 May 2015 10:00 | -0.20 | -0.14 | +31.2% | Beat |
| 27 Feb 2015 09:00 | 0.04 | 0.16 | +325.3% | Beat |
| 07 Nov 2014 08:00 | -0.20 | -0.23 | -12.2% | Miss |
| 04 Aug 2014 08:00 | -0.11 | -0.10 | +11.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 943.7M | +33.8% | -381.4M | -40.4% | -2.38 | +21.7% | -325.7M |
| 2024 | 705.1M | -10.5% | -453.9M | -64.4% | -3.04 | -18.8% | -551.3M |
| 2023 | 787.6M | +34.1% | -366.3M | -46.5% | -2.56 | -34.7% | -335.5M |
| 2022 | 587.4M | — | -269.7M | -45.9% | -1.90 | — | -294.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 28.07 | 28.56 | 27.28 | 27.31 | -3.60% | 6,198,900 | |
| 11 Nov 2026 | 28.60 | 29.42 | 28.25 | 28.33 | +0.50% | 6,550,900 | |
| 10 Nov 2026 | 30.31 | 30.49 | 27.77 | 28.19 | -9.06% | 10,686,900 | |
| 09 Nov 2026 | 32.27 | 32.58 | 27.75 | 31.00 | -21.36% | 19,500,100 | |
| 06 Nov 2026 | 39.02 | 40.00 | 38.53 | 39.42 | +1.60% | 2,911,800 | |
| 05 Nov 2026 | 40.31 | 40.50 | 38.31 | 38.80 | -3.36% | 2,974,800 | |
| 04 Nov 2026 | 41.38 | 41.53 | 39.33 | 40.15 | -0.67% | 4,102,700 | |
| 03 Nov 2026 | 41.26 | 41.83 | 40.26 | 40.42 | -1.99% | 4,006,900 | |
| 02 Nov 2026 | 43.66 | 43.91 | 41.19 | 41.24 | -5.24% | 2,559,000 | |
| 30 Oct 2026 | 44.69 | 45.12 | 43.27 | 43.52 | -1.96% | 1,522,100 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Ionis to present at upcoming investor conferences (opens in a new tab) 10 Nov 2026 12:05
- Ionis Pharmaceuticals Inc (IONS) (Q3 2026) Earnings Call Highlights: DAWNZERA Momentum and ... (opens in a new tab) GuruFocus.com · 10 Nov 2026 11:02
- HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $70 (opens in a new tab) Benzinga · 10 Nov 2026 08:09
- Ionis Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 10 Nov 2026 02:20
- Ionis Stock In Focus After Revenue Beat And Reaffirmed 2026 Outlook (opens in a new tab) Simply Wall St. · 10 Nov 2026 02:13
- Ionis: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 10 Nov 2026 00:13
- Ionis (IONS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 09 Nov 2026 23:44
- Ionis Is Among The Worst Performers In Its Industry Group Today. Here's Why. (opens in a new tab) Investor's Business Daily · 09 Nov 2026 21:18
- Ionis Pharmaceuticals: Q3 Triggers The Latest Selloff On Tryngolza Disappointment (opens in a new tab) SeekingAlpha · 09 Nov 2026 17:35
- What Ionis Pharmaceuticals (IONS) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 09 Nov 2026 17:14
- Ionis Pharmaceuticals, Inc. (IONS) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 09 Nov 2026 16:40
- Ionis Pharmaceuticals Reports 55% Rise in Q3 Revenue to $243 Million, Cuts TRYNGOLZA Sales Guidance (opens in a new tab) InvestorsHub · 09 Nov 2026 16:01
- Ionis Slashes Key Drug Revenue Outlook by 50%, Sending Stock Sharply Lower (opens in a new tab) Barrons.com · 09 Nov 2026 15:16
- Why Is Ionis Pharmaceuticals Stock at a 52-Week Low on Monday? (opens in a new tab) Benzinga · 09 Nov 2026 14:33
- Ionis Pharmaceuticals (IONS) Reports Q3 Earnings: What Key Metrics Have to Say (opens in a new tab) Zacks · 09 Nov 2026 13:30
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 28.33 USD
- Market cap
- 4.5B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow IONS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.